Bill Snyder
-
Team isolates new antibodies that may aid RSV vaccine design
Researchers at Vanderbilt University Medical Center (VUMC) have taken another step toward developing a vaccine against respiratory syncytial virus (RSV), the major cause of life-threatening pneumonia in infants worldwide. Read MoreFeb 9, 2017
-
Gene mutation discovery may hold autism clues: study
Researchers at Vanderbilt have identified what may be a genetic “smoking gun” for autism spectrum disorder (ASD) — a mutation in the gene for the critical neuronal protein CaMKII. Read MoreFeb 2, 2017
-
Patient and Family Promise key to Medical Center’s success
Vanderbilt University Medical Center (VUMC) makes this promise to patients and their families: to include them as a member of the health care team, respect their privacy, coordinate and personalize their care, communicate clearly and serve them with kindness and respect. Delivering on that promise was the theme of Wednesday’s Winter Leadership Assembly in Langford Auditorium. Read MoreFeb 2, 2017
-
New Physician Science Doctoral Program graduates first student
As a fellow in pulmonary and critical care medicine at Vanderbilt University School of Medicine, Bradley Richmond, M.D., saw a lot of patients with chronic obstructive pulmonary disease (COPD), an inflammatory lung disease caused most often by long-term exposure to cigarette smoke. Read MoreFeb 2, 2017
-
New management software bolsters research cores
This month the Office of Research at Vanderbilt University Medical Center (VUMC) began transitioning VUMC research cores, facilities and shared resources (known collectively as “cores”) to a new core management application that officials said will streamline ordering and billing for core services. Read MoreJan 26, 2017
-
Global health meet explores future needs
The health of people around the world depends to a large extent on the ability of the global health community to predict what challenges must be met in the future. Read MoreJan 26, 2017
-
Casagrande recalled as neuroscience pillar, supportive mentor
Vivien Casagrande, Ph.D., a neuroscientist and professor at Vanderbilt University School of Medicine (VUSM) noted for her many contributions to the visual sciences, died peacefully at her home on Saturday, Jan. 21. She was 74. Read MoreJan 24, 2017
-
Saliva test for obesity risk
“Epigenetic signatures” in DNA may present an opportunity for prevention of or early intervention in childhood obesity. Read MoreJan 24, 2017
-
Surprising finding by VU team sheds light on fibrotic disease
Integrins are membrane proteins made up of combinations of different “alpha” and “beta” subunits that enable cells throughout the body to interact with their surroundings. Read MoreJan 19, 2017
-
COX-2 ‘conjugate’ may slow growth of some tumors: study
More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents. Read MoreJan 19, 2017
-
GRE may be poor predictor of science success: study
Since it was created in 1949, the Graduate Record Exam (GRE) has been one of the most widely used requirements for admission to U.S. graduate schools. As a predictor of performance and success in graduate school, however, the exam is not without its critics. Read MoreJan 19, 2017
-
Amount of daylight may impact serotonin programming
The duration of exposure to daylight, or the “photoperiod,” may affect development of seasonal affective disorder by programming serotonin neurons in the brain, according to Vanderbilt University researchers. Read MoreJan 19, 2017
-
A heart-brain connection
Cognitive and attention deficits observed in children following surgery before age 5 to repair congenital heart defects likely will persist into their teens and young adulthood. Read MoreJan 17, 2017
-
Lindsley’s drug discovery efforts land ASPET Award
Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read MoreJan 12, 2017
-
Team’s discovery offers new insight on lung cancer risk
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts. Read MoreJan 12, 2017
-
Nominations sought for Vanderbilt Prize in Biomedical Science
Nominations for the 2017 Vanderbilt Prize in Biomedical Science are now being accepted. The deadline is March 31. Read MoreJan 12, 2017
-
Department of Medicine’s NIH funding swells
Vanderbilt University School of Medicine has long been recognized as a national leader in biomedical research. Nowhere is this more evident than in the school’s Department of Medicine, which, during the 2016 federal fiscal year that ended Sept. 30, broke another record. Read MoreJan 5, 2017
-
Daughter’s rare adverse drug reaction inspires family’s donation
Last year Paul and Wanpen Anderson of Champaign, Illinois, were preparing to celebrate the Christmas holidays with their two children when their 22-year-old daughter, Angela, developed a rare adverse drug reaction called SJS/TEN. Read MoreDec 21, 2016
-
New clues emerge in rare form of childhood epilepsy
Researchers at Vanderbilt University Medical Center (VUMC) are one step closer to understanding what causes early-onset epileptic encephalopathy, a rare form of childhood epilepsy that is difficult to treat and has poor developmental outcomes. Read MoreDec 15, 2016
-
Symposium honors Casagrande’s career
Colleagues of Vivien Casagrande, Ph.D., celebrated her distinguished career in the visual sciences with a “Lifetime of Vision” symposium Nov. 18 in Biological Sciences/Medical Research Building III. Read MoreDec 1, 2016